母亲糖尿病与子代神经发育结局的关联:纳入56·1百万妊娠的202项观察性研究的系统综述与Meta分析
该系统综述与Meta分析纳入202项观察性研究、涉及56 082 462对母子,评估母亲糖尿病与子代神经发育结局的关联。在多混杂因素校正的研究中,母亲糖尿病与子代任何神经发育障碍风险升高相关(RR 1·28,95%CI 1·24-1·31),且孕前糖尿病关联强于妊娠糖尿病(RR 1·39 vs 1·18,亚组差异P<0·0001)。作者认为需进一步高质量研究确立因果。
要点
- 母亲糖尿病与子代任何神经发育障碍风险升高相关(RR 1·28,95%CI 1·24-1·31)。
- 孕前糖尿病与子代多数神经发育障碍的关联强于妊娠糖尿病(RR 1·39 vs 1·18,亚组差异P<0·0001)。
- 作者认为需进一步高质量研究确立因果并明确特定糖尿病类型与全谱神经发育障碍的关联。
核心结论
- 母亲糖尿病与子代神经发育障碍风险升高及神经发育表现受损相关。
- 作者认为需进一步高质量研究确立因果并明确特定糖尿病类型与全谱神经发育障碍的关联。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Web of Science、Embase和EBSCO数据库自建库至2024年12月1日。
- 纳入202项观察性研究,涉及56 082 462对母子;其中110项(54%)研究妊娠糖尿病,80项(40%)研究孕前糖尿病。
- 169项(84%)研究仅关注至18岁的儿童和青少年;98项(49%)研究校正了多个混杂因素。
- 数据采用随机效应模型合并,以风险比或标准均数差及95%CI呈现;研究前瞻性注册于PROSPERO(CRD42023395464)。
主要发现
- 在校正多个混杂因素的研究(n=98,49%)中,与未暴露儿童相比,母亲糖尿病暴露儿童任何神经发育障碍风险升高(RR 1·28,95%CI 1·24-1·31)。
- 孤独症谱系障碍风险升高(RR 1·25,95%CI 1·20-1·31),注意缺陷多动障碍风险升高(RR 1·30,95%CI 1·24-1·37)。
- 智力障碍风险升高(RR 1·32,95%CI 1·18-1·47),特定发育障碍风险升高(RR 1·27,95%CI 1·17-1·37)。
- 交流障碍风险升高(RR 1·20,95%CI 1·11-1·28),运动障碍风险升高(RR 1·17,95%CI 1·10-1·26),学习障碍风险升高(RR 1·16,95%CI 1·06-1·26)。
- 孕前糖尿病与子代多数神经发育障碍风险的关联强于妊娠糖尿病(RR 1·39,95%CI 1·34-1·44 vs RR 1·18,95%CI 1·14-1·23;亚组差异P<0·0001)。
关键数值与推荐
- 主要结局为神经发育障碍,依据《精神障碍诊断与统计手册》第五版和《国际疾病分类》第十一版定义。
- 在校正至少一个关键混杂因素的研究中,母亲糖尿病与所有类型神经发育障碍风险升高以及智力和精神运动评分降低相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者认为需进一步高质量研究确立因果并明确特定糖尿病类型与全谱神经发育障碍的关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Maternal diabetes might alter fetal brain development. However, well-designed systematic analyses are needed to comprehensively assess and quantify the association between maternal diabetes and neurodevelopmental outcomes in children. We aimed to synthesise and evaluate the available evidence on the effects of maternal diabetes on neurodevelopmental outcomes in children. METHODS: For this systematic review and meta-analysis we searched PubMed, Web of Science, Embase, and EBSCO databases from inception to Dec 1, 2024, for studies exploring neurodevelopmental outcomes of children born to mothers with diabetes. The primary outcome was neurodevelopmental disorders, as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition and International Classification of Diseases 11th Revision. Data were extracted from published reports. Data were pooled with random-effects models and presented as risk ratios or standard mean differences with 95% CIs. This study was prospectively registered on PROSPERO (CRD42023395464). FINDINGS: 202 studies, involving 56 082 462 mother-child pairs, were included in the meta-analysis. Of these, 110 (54%) examined gestational diabetes, while 80 (40%) investigated pre-gestational diabetes. Among the total studies reviewed, 169 (84%) exclusively focused on children and adolescents aged up to 18 years. In studies adjusting for at least one key confounder, maternal diabetes was associated with increased risks of all types of neurodevelopmental disorders as well as lower intelligence and psychomotor scores. In studies adjusting for multiple confounders (n=98, 49%), children exposed to maternal diabetes had an increased risk of any neurodevelopmental disorder (risk ratio 1·28; 95% CI 1·24-1·31), autism spectrum disorder (1·25; 1·20-1·31), attention-deficit hyperactivity disorder (1·30; 1·24-1·37), intellectual disability (1·32; 1·18-1·47), specific developmental disorders (1·27; 1·17-1·37), communication disorder (1·20; 1·11-1·28), motor disorder (1·17; 1·10-1·26), and learning disorder (1·16; 1·06-1·26), compared with unexposed children. Maternal pre-gestational diabetes was more strongly associated with the risk of most neurodevelopmental disorders in children than gestational diabetes (risk ratio 1·39; [95% CI 1·34-1·44] vs 1·18 [1·14-1·23]; subgroup difference p<0·0001). INTERPRETATION: Maternal diabetes is associated with an increased risk of neurodevelopmental disorders and impaired neurodevelopmental performance in children. Further high-quality research is needed to establish causality and clarify the associations between specific types of diabetes and the full spectrum of neurodevelopmental disorders. FUNDING: The National Natural Science Foundation of China, and the Science and Technology Innovation Program of Hunan Province. TRANSLATION: For the Mandarin translation of the abstract see Supplementary Materials section.
引用
- Ye W, Luo C, Zhou J, et al. Association between maternal diabetes and neurodevelopmental outcomes in children: a systematic review and meta-analysis of 202 observational studies comprising 56·1 million pregnancies. Lancet Diabetes Endocrinol. 2025. PMID: 40209722. doi:10.1016/S2213-8587(25)00036-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。